Lidocaine Hydrochloride Injection, Solution
Product Images NDC 55154-8337

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 55154-8337). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

C8ba5acc 4a8d 490a Ad49 9cfb89abe015 00

C8ba5acc 4a8d 490a Ad49 9cfb89abe015 00
This is a description of a 1% Lidocaine HCl injection, USP, containing 200 mg per 20 mL (10mg/mL), meant for infiltration and nerve block. It is not meant for caudal or epidural use. The injection comes in 20 mL multiple dose vials and is preserved with methylparaben. Each mL contains 10 mg of Lidocaine hydrochloride USP, which is equivalent to 8.65 mg of Lidocaine. Other ingredients include sodium chloride, methylparaben (1mg), and sodium hydroxide or hydrochloric acid to adjust pH. The usual dosage is stated on the product and warnings for use are also included. The injection vials can be resterilized by autoclaving and should be stored between 20-25°C. The package is not child-resistant, and the product is intended for institutional use only. It is distributed by AuroMedics Pharma LLC and made in India.*
FDA Label Image

Lidocaine Hydrochloride Chemical Structure (Lidocaine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.